Liposomal Irinotecan Clinical Trials
5 recruitingDrug
Phase 13Phase 22Not Applicable1
Showing 1–5 of 5 trials
Recruiting
Phase 2
Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic Adenocarcinoma
Medical University of South Carolina52 enrolled1 locationNCT07076212
Recruiting
Phase 1
A Study of ASP3082 in Adults With Advanced Solid Tumors
Solid Tumor
Astellas Pharma Inc681 enrolled53 locationsNCT05382559
Recruiting
Phase 1Phase 2
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
OsteosarcomaOsteosarcoma Metastatic
Peking University People's Hospital56 enrolled1 locationNCT07479732
Recruiting
Not Applicable
SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
Rectal Cancer, Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology49 enrolled1 locationNCT07474103
Recruiting
Phase 1
Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Toripalimab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement
Rectal Cancer
Affiliated Cancer Hospital of Shantou University Medical College59 enrolled1 locationNCT07104604